OTCQB Podcast

Hemostemix Inc.


Listen Later

Hemostemix Inc. (OTCQB: HMTXF) is a patient's own stem cell therapy company that holds 91 patents. A winner of the World Economic Forum Technology Pioneer Award, the Company has developed patented, and is scaling a patient's blood-based stem cell therapeutics platform. Thomas Smeenk, President, CEO and Co-Founder of Hemostemix, joins us today to share his personal story and inspiration for creating this company to help others.

View Podcast Transcript

...more
View all episodesView all episodes
Download on the App Store

OTCQB PodcastBy OTC Markets Group

  • 4.2
  • 4.2
  • 4.2
  • 4.2
  • 4.2

4.2

10 ratings